Ari J. Isaacson
Research Subjects
Ari J. Isaacson has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Hyeon Yu
Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina at Chapel Hill, 2018 Old Clinic, CB 7510, Chapel Hill, NC 27599, USA
14 shared publications Sandeep Bagla
Hemorrhoid Centers USA, 2755 Hartland Road, Falls Church, VA 22043
13 shared publicationsCharles T. Burke
Department of Radiology, University of North Carolina School of Medicine, 517 Old Infirmary, CB 7510, 101 Manning Dr., Chapel Hill, NC 27599
9 shared publications- Abin Sajan
Department of Radiology, Columbia University Medical Center, New York, New York
6 shared publications Rachel Piechowiak
Prostate Centers USA, 1801 Robert Fulton Drive Suite 510, Reston, VA 20191
5 shared publicationsRobert G. Dixon
Department of Radiology, University of North Carolina, 101 Manning Dr., Chapel Hill, NC 27514
4 shared publications
Latest Publications
- 14 January 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (5) , 913-915
Angiographic Analysis of Anatomical Variants in 242 Hemorrhoidal Artery Embolization
- 14 January 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (5) , 913-915
Angiographic Analysis of Anatomical Variants in 242 Hemorrhoidal Artery Embolization
- Top Cited Papers
- 27 April 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 35 (8) , 1097-1103
Society of Interventional Radiology Research Reporting Standards for Genicular Artery Embolization
- 27 April 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 35 (8) , 1097-1103
Top Cited PapersSociety of Interventional Radiology Research Reporting Standards for Genicular Artery Embolization
- 1 February 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (5) , 745-749
Outcomes of Hemorrhoidal Artery Embolization from a Multidisciplinary Outpatient Interventional Center
- 1 February 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (5) , 745-749
Outcomes of Hemorrhoidal Artery Embolization from a Multidisciplinary Outpatient Interventional Center
- 7 August 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (11) , 1449-1452
Embolization for the Treatment of Hemorrhage after Pelvic Urethral Lift
- 7 August 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (11) , 1449-1452
Embolization for the Treatment of Hemorrhage after Pelvic Urethral Lift
- 27 April 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (5) , 558-563.e1
Nontarget Radiopaque Embolic Deposition during Prostatic Artery Embolization
- 27 April 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (5) , 558-563.e1
Nontarget Radiopaque Embolic Deposition during Prostatic Artery Embolization
- 1 April 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (4) , 359-367.e8
Minimally Invasive Treatments for Benign Prostatic Hyperplasia: Systematic Review and Network Meta-Analysis
- 1 April 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (4) , 359-367.e8
Minimally Invasive Treatments for Benign Prostatic Hyperplasia: Systematic Review and Network Meta-Analysis
- 1 March 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (3) , 238-248.e4
Comparison of Minimally Invasive Procedures to Treat Knee Pain Secondary to Osteoarthritis: A Systematic Review and Meta-Analysis
- 1 March 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (3) , 238-248.e4
Comparison of Minimally Invasive Procedures to Treat Knee Pain Secondary to Osteoarthritis: A Systematic Review and Meta-Analysis
- Open Access
- 24 November 2021
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 38 (05) , 511-514
Musculoskeletal Interventions: A Review on Genicular Artery Embolization
Symptomatic knee pain is one of the most common joint diseases that affects millions of people worldwide. The treatment for knee pain secondary to osteoarthritis (OA) begins with conservative therapy and progresses to surgical intervention when conservative therapy fails. Genicular artery embolization (GAE) offers an alternative option for patients who are poor surgical candidates. Multiple studies have been conducted worldwide demonstrating the safety and efficacy of GAE in patients with mild to moderate OA. The purpose of this article is to describe the current literature on GAE and highlight the latest findings from a randomized controlled trial comparing GAE versus sham embolization. • S.B. is a consultant for Boston Scientific, Varian Medical Systems, Medtronic, Embolx, IMBiotechnologies, and Phillips Medical System. • A.I. is a consultant for Terumo, ABK Biomedical, and CrannMed. • No other disclosures or conflicts of interest. Publication Date: 24 November 2021 (online) © 2021. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 24 November 2021
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 38 (05) , 511-514
Open AccessMusculoskeletal Interventions: A Review on Genicular Artery Embolization
Symptomatic knee pain is one of the most common joint diseases that affects millions of people worldwide. The treatment for knee pain secondary to osteoarthritis (OA) begins with conservative therapy and progresses to surgical intervention when conservative therapy fails. Genicular artery embolization (GAE) offers an alternative option for patients who are poor surgical candidates. Multiple studies have been conducted worldwide demonstrating the safety and efficacy of GAE in patients with mild to moderate OA. The purpose of this article is to describe the current literature on GAE and highlight the latest findings from a randomized controlled trial comparing GAE versus sham embolization. • S.B. is a consultant for Boston Scientific, Varian Medical Systems, Medtronic, Embolx, IMBiotechnologies, and Phillips Medical System. • A.I. is a consultant for Terumo, ABK Biomedical, and CrannMed. • No other disclosures or conflicts of interest. Publication Date: 24 November 2021 (online) © 2021. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- Open Access
- 31 March 2021
- Published by Springer Nature in CVIR Endovascular
- Vol. 4 (1) , 1-7
Initial experience with HydroPearl microspheres for uterine artery embolization for the treatment of symptomatic uterine fibroids
Background: Uterine Artery Embolization (UAE) is a minimally invasive procedure used to treat symptomatic uterine fibroids. The HydroPearl Microsphere (Terumo Interventional Systems) is an embolic agent approved for UAE and other embolization procedures. The purpose of this article is to describe our initial experience with HydroPearl for UAE in patients with symptomatic uterine fibroids. Twenty-one patients who underwent UAE using HydroPearl Microspheres at a single institution from May 1, 2018 to December 31, 2019 were included in the study. The electronic medical record (EMR) was reviewed for documentation of short- and long-term complications, as well as improvements in menorrhagia and bulk-type symptoms. We also describe unique attributes of the HydroPearl Microsphere that should be considered when utilizing this embolization particle for UAE. Results: Of the 21 patients, 18 had a 3-month or later post-procedure follow-up documented in the EMR and were included in the analysis. The average time between the UAE procedure and the most recent clinical note was 145 days. Sixteen patients reported symptoms of menorrhagia and 13 reported bulk symptoms prior to the UAE procedure. On follow-up, 13/16 patients (81%) and 12/13 patients (92%) experienced improvement in menorrhagia and bulk symptoms, respectively. The only recorded complication was amenorrhea in 4 patients (22%) who had an average age of 51 years. Conclusions: Several characteristics of HydroPearl Microsphere may prove helpful when considering these embolic particles for use in UAE. Our initial experience with this embolic agent suggest that the reatment response for menorrhagia and bulk symptoms are largely similar to success rates reported in the literature for other embolic agents. Larger studies are needed to evaluate the safety and efficacy of this embolic particle for this indication.
- 31 March 2021
- Published by Springer Nature in CVIR Endovascular
- Vol. 4 (1) , 1-7
Open AccessInitial experience with HydroPearl microspheres for uterine artery embolization for the treatment of symptomatic uterine fibroids
Background: Uterine Artery Embolization (UAE) is a minimally invasive procedure used to treat symptomatic uterine fibroids. The HydroPearl Microsphere (Terumo Interventional Systems) is an embolic agent approved for UAE and other embolization procedures. The purpose of this article is to describe our initial experience with HydroPearl for UAE in patients with symptomatic uterine fibroids. Twenty-one patients who underwent UAE using HydroPearl Microspheres at a single institution from May 1, 2018 to December 31, 2019 were included in the study. The electronic medical record (EMR) was reviewed for documentation of short- and long-term complications, as well as improvements in menorrhagia and bulk-type symptoms. We also describe unique attributes of the HydroPearl Microsphere that should be considered when utilizing this embolization particle for UAE. Results: Of the 21 patients, 18 had a 3-month or later post-procedure follow-up documented in the EMR and were included in the analysis. The average time between the UAE procedure and the most recent clinical note was 145 days. Sixteen patients reported symptoms of menorrhagia and 13 reported bulk symptoms prior to the UAE procedure. On follow-up, 13/16 patients (81%) and 12/13 patients (92%) experienced improvement in menorrhagia and bulk symptoms, respectively. The only recorded complication was amenorrhea in 4 patients (22%) who had an average age of 51 years. Conclusions: Several characteristics of HydroPearl Microsphere may prove helpful when considering these embolic particles for use in UAE. Our initial experience with this embolic agent suggest that the reatment response for menorrhagia and bulk symptoms are largely similar to success rates reported in the literature for other embolic agents. Larger studies are needed to evaluate the safety and efficacy of this embolic particle for this indication.
- Open Access
- 25 January 2021
- Published by Georg Thieme Verlag KG in Journal of Clinical Interventional Radiology ISVIR
- Vol. 5 (01) , 48-50
Prostatic Artery Embolization through the Profunda Femoris Artery
An 88-year-old catheter-dependent patient with peripheral vascular disease and benign prostatic hyperplasia was referred for prostatic artery embolization (PAE). Selective angiography of the left internal iliac artery (IIA) revealed a 2.5-cm aneurysm and a single artery comprising the anterior division of the IIA (inferior gluteal artery). No prostatic artery (PA) was identified on the left. Additional angiography of the left external iliac artery (EIA), right IIA, and right EIA did not demonstrate prostatic perfusion. The right profunda femoris artery was then selected given previously reported atherosclerotic collaterals, which revealed an ascending branch of the medial circumflex femoral artery coursing through the upper thigh into the pelvis and reconstituting the right anterior division of the IIA. A 2.4-French microcatheter (Terumo) and 0.018-inch wire (Transcend, Boston Scientific) were used to enter the pelvic vasculature, right PA was identified, and a 2-mm coil was used to perform embolization of a potential nontarget anterior division branch. Embolization of the right PA was then performed with 250-µm particulate and Gelfoam slurry. Two-week follow-up revealed spontaneous voiding and catheter independence.
- 25 January 2021
- Published by Georg Thieme Verlag KG in Journal of Clinical Interventional Radiology ISVIR
- Vol. 5 (01) , 48-50
Open AccessProstatic Artery Embolization through the Profunda Femoris Artery
An 88-year-old catheter-dependent patient with peripheral vascular disease and benign prostatic hyperplasia was referred for prostatic artery embolization (PAE). Selective angiography of the left internal iliac artery (IIA) revealed a 2.5-cm aneurysm and a single artery comprising the anterior division of the IIA (inferior gluteal artery). No prostatic artery (PA) was identified on the left. Additional angiography of the left external iliac artery (EIA), right IIA, and right EIA did not demonstrate prostatic perfusion. The right profunda femoris artery was then selected given previously reported atherosclerotic collaterals, which revealed an ascending branch of the medial circumflex femoral artery coursing through the upper thigh into the pelvis and reconstituting the right anterior division of the IIA. A 2.4-French microcatheter (Terumo) and 0.018-inch wire (Transcend, Boston Scientific) were used to enter the pelvic vasculature, right PA was identified, and a 2-mm coil was used to perform embolization of a potential nontarget anterior division branch. Embolization of the right PA was then performed with 250-µm particulate and Gelfoam slurry. Two-week follow-up revealed spontaneous voiding and catheter independence.